Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose–Efficacy Modeling
暂无分享，去创建一个
R. Price | D. Fidock | R. Sinden | R. de Kanter | K. Dechering | M. Delves | D. Leroy | R. Sauerwein | R. Noviyanti | J. Marfurt | R. Brun | J. Burrows | M. Clozel | Francisco Javier Gamo-Benito | M. Jiménez-Díaz | M. Martínez | Iñigo Angulo-Barturen | S. Ferrer | Stephan Buchmann | S. Wittlin | W. Fischli | T. Weller | C. Boss | C. Binkert | Solange Meyer | Nina F. Gnädig | Caroline L. Ng | J. Straimer | Bibia Heidmann | A. Ruecker | Grennady Wirjanata | Christopher Snyder | C. Scheurer | Christoph Fischli | S. Ewerling | R. Brunner | Amélie Le Bihan | L. Sanz | Joerg J. Moehrle | Sarah Schleiferboeck | Rintis Noviyanti